Equity Capital Markets

CytomX Therapeutics Inc.

05/25
|
$100.0 Million
cytomx
Piper Sandler served as bookrunner for CytomX Therapeutics Inc. on its RD
Sub-Type
Registered Direct
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$993.6 Million
chime
Chime Financial, Inc.
Initial Public Offering
Passive Bookrunner
$45.9 Million
OC
Orange County Bancorp, Inc.
Follow-On Common Stock Offering
Lead Bookrunner
$845.2 Million
birkenstock
Birkenstock Holding
Confidentially Marketed Follow-On Offering
Co-Manager
$683.6 Million
galaxy
Galaxy Digital Holdings Ltd.
Follow-On Offering
Passive Bookrunner
$200.0 Million
taysha
Taysha Gene Therapies
Confidentially Marketed Follow-On Offering
Active Bookrunner
$502.9 Million
hinge
Hinge Health, Inc.
Initial Public Offering
Passive Bookrunner
$138.7 Million
savers
Savers Value Village
Follow-On Offering
Passive Bookrunner
$372.9 Million
klaviyo
Klaviyo Inc.
Follow-On Offering
Passive Bookrunner
$215.0 Million
Busey
First Busey Corporation
Perpetual Preferred Stock
Lead Bookrunner
cytomx
CytomX Therapeutics Inc.
Follow-On Offering
Co-Manager
$100.0 Million
cytomx
CytomX Therapeutics Inc.
Underwritten Registered Direct Offering
Active Bookrunner
$397.5 Million
Aspen
Aspen Insurance Holdings Ltd.
Initial Public Offering
Passive Bookrunner
$2.0 Billion
annaly
Annaly Capital Management
ATM Program Common Stock
Lead Placement Agent
$110.0 Million
american
American Integrity Insurance Co.
Initial Public Offering
Lead Bookrunner
$50.0 Million
ready
Ready Capital
Senior Secured Notes
Sole Placement Agent
$419.8 Million
Marex
Marex Group plc
Follow-On Offering
Passive Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.